1
Clinical Trials associated with Allogenic Islet Cell Transplantation(University of Virginia) / Unknown statusPhase 1/2IIT A Phase I/II, Open-Arm Study Evaluating the Safety of Islet Transplant in Patients With Type I Diabetes
The primary objective of this study is to demonstrate the safety of allogenic islet transplantation in type 1 diabetic patients performed at the University of Virginia.
The purpose is to demonstrate that islet transplantation can be performed safely and reliably achieves better glycemic control than state-of-the-art insulin treatment in management of type 1 diabetic patients with brittle control and a history of severe hypoglycemic episodes with hypoglycemia unawareness.
100 Clinical Results associated with Allogenic Islet Cell Transplantation(University of Virginia)
100 Translational Medicine associated with Allogenic Islet Cell Transplantation(University of Virginia)
100 Patents (Medical) associated with Allogenic Islet Cell Transplantation(University of Virginia)
100 Deals associated with Allogenic Islet Cell Transplantation(University of Virginia)